Építés alatt – nem éles oldal
Belépés
Még nem keres résztvevőt itt: Egyesült ÁllamokFázis nélkül

Motus Nova Foot Device for Patients With Hemiplegia

A legfontosabb adatok

Hol
Puyallup (Egyesült Államok)A helyszín megnézése

Neked szólhat?

Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.

  • 12 és 20 év között vagy?

Forrás: NCT07754773: ki vehet részt

Helyszínek itt: Egyesült Államok

  • Mary Bridge Children's Therapy Research & Movement LabPuyallup, Egyesült ÁllamokContact: Brenna Brandsma, PT, DPT, PCSNo longer taking part

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

A vizsgálat adatai

Ki végzi
MultiCare Health System Research Institute
Azonosító
NCT07754773
A regiszteradat frissítve
2026. augusztus 10.
Eredeti leírás
Individuals with hemiplegia commonly demonstrate gait deviations such as difficulties with heel strike at initial contact, foot drop in swing, asymmetrical limb loading, muscle activation, and balance impairments. This study evaluates whether a therapeutic device (Motus Nova Foot; FDA approved) used in the home setting can increase heel strike, decrease limp, improve foot clearance in swing phase, improve quality of active muscle contraction of the affected limb, and improve balance. The Motus Nova Foot moves the ankle/foot and uses guided computer/video activities to encourage active participation while automatically recording device use and duration.A teljes eredeti leírásKevesebb

Evaluating Gait After Use of The Motus Nova Foot Device for Patients With Hemiplegia

Individuals with hemiplegia commonly demonstrate gait deviations such as difficulties with heel strike at initial contact, foot drop in swing, asymmetrical limb loading, muscle activation, and balance impairments. This study evaluates whether a therapeutic device (Motus Nova Foot; FDA approved) used in the home setting can increase heel strike, decrease limp, improve foot clearance in swing phase, improve quality of active muscle contraction of the affected limb, and improve balance. The Motus Nova Foot moves the ankle/foot and uses guided computer/video activities to encourage active participation while automatically recording device use and duration.

Bevonási feltételek: Age 12-20 years; Diagnosis consistent with hemiplegia and gait/balance impairments involving ankle/foot control (e.g., reduced heel strike); Able to ambulate and safely participate in laboratory walking and balance testing; Able to follow instructions and use the Motus Nova Foot system at home with family support as needed; Willingness to refrain from standard clinic-based PT during the study period.

Kizáró feltételek: Skin integrity issues or hypersensitivity preventing safe use of straps/pads; Medical/orthopedic conditions making walking or balance testing unsafe (e.g., unstable seizures, recent surgery, acute injury); Heart conditions that prevent physical activity; Inability to safely use the device as determined during fitting/training; Planned participation in standard clinic-based PT during the study period; Electrical stimulation device to lower extremity within 6 months of study start, or planned use of electrical stimulation to lower extremity during study period; Pregnancy.

ClinicalTrials.gov NCT07754773